Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
EKSO BIONICS HOLDINGS, INC. (EKSO)
|
Add to portfolio |
|
|
|
| Price: |
$6.32
| | Metrics |
| OS: |
13.8
|
M
| |
|
|
| Market cap: |
$87.3
|
M
| |
|
|
|
Net cash:
|
$7.07
|
M
| |
$0.51
|
per share
|
|
EV:
|
$80.2
|
M
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
($14.1)
|
M
| |
|
|
|
EBIT
|
|
| |
|
|
| EPS |
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 |
| Revenues | 11.2 | 8.9 | 13.9 | 11.3 | 7.4 | 14.2 | 8.7 | 5.3 |
| Revenue growth | 26.6% | -36.2% | 22.8% | 54.1% | -48.3% | 64.2% | 62.6% | 61.3% |
| Cost of goods sold | 4.5 | 3.8 | 7.2 | 7.0 | 5.3 | 11.3 | 7.5 | 3.8 |
| Gross profit | 6.7 | 5.1 | 6.8 | 4.3 | 2.1 | 2.9 | 1.2 | 1.6 |
| Gross margin | 60.0% | 57.1% | 48.6% | 38.0% | 28.1% | 20.7% | 13.6% | 29.3% |
| Selling, general and administrative | | | | | | | | |
| Sales and marketing | 7.3 | 7.8 | 11.4 | 13.8 | 13.2 | 11.0 | 9.3 | 7.1 |
| Research and development | 2.7 | 2.5 | 4.6 | 5.8 | 9.5 | 8.9 | 6.5 | 3.9 |
| General and administrative | 10.5 | 7.7 | 7.4 | 11.7 | 10.7 | 10.9 | 7.0 | 7.4 |
| EBITA | -13.8 | -12.9 | -16.6 | -27.0 | -31.1 | -27.0 | -21.5 | -16.8 |
| EBITA margin | -123.0% | -144.8% | -119.6% | -238.5% | -422.6% | -190.1% | -248.6% | -315.3% |
| Amortization of intangibles | | | | | 0.5 | 0.6 | 0.0 | |
| EBIT | -13.8 | -12.9 | -16.6 | -27.0 | -31.6 | -27.6 | -21.6 | -16.8 |
| EBIT margin | -123.0% | -144.8% | -119.6% | -238.5% | -429.9% | -194.0% | -248.9% | -315.3% |
| Pre-tax income | -9.8 | -15.8 | -12.1 | -27.0 | -29.1 | -23.5 | -19.6 | -33.8 |
| Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | -9.8 | -15.8 | -12.1 | -27.0 | -29.1 | -33.8 | -24.2 | 0.0 |
| Net margin | -86.8% | -178.2% | -87.2% | -238.2% | -396.1% | -237.8% | -279.9% | -0.6% |
| |
| Diluted EPS | ($0.80) | ($2.21) | ($2.53) | ($0.44) | ($0.82) | ($1.82) | ($1.66) | ($3.02) |
| Shares outstanding (diluted) | 12.3 | 7.2 | 4.8 | 61.2 | 35.6 | 18.6 | 14.6 | 0.0 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|